• Biotech Breakthroughs – The Future of GLP-1s

  • Jun 12 2024
  • Duración: 23 m
  • Podcast

Biotech Breakthroughs – The Future of GLP-1s

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Biotech equity research analysts Andy Hsieh and Matt Phipps join group head Tim Lugo to discuss the latest developments in GLP-1s for diabetes and obesity treatment, including the emergence of oral therapies and the profound weight loss results seen in recent data sets. The conversation also covers the commercial trajectory of drugs like semaglutide and tirzepatide, the potential for market growth, and the challenges of patient retention and reimbursement, concluding with a look at the future of the field, including the exploration of new mechanisms and the focus on quality of weight loss.
    Más Menos
activate_primeday_promo_in_buybox_DT
Economía Finanzas Personales
Más Menos

Lo que los oyentes dicen sobre Biotech Breakthroughs – The Future of GLP-1s

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles